Lack of Effect of P-glycoprotein Inhibition on Renal Clearance of Dicloxacillin in Patients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Lack of Effect of P-glycoprotein Inhibition on Renal Clearance of Dicloxacillin in Patients with Cystic Fibrosis

Published:2008-07 Issue:7 Volume:28 Page:883-894
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Beringer Paul M,Kriengkauykiat Jane,Zhang Xiyun,Hidayat Levita,Liu Shanshan,Louie Stan,Synold Tim,Burckart Gilbert J,Rao Purush A,Shapiro Bertrand,Gill Mark

Publisher

Wiley

Subject

Pharmacology (medical)

Reference24 articles.

1. Cystic fibrosis.

2. Pathogenesis of cystic fibrosis

3. Reduction of SputumPseudomonas aeruginosaDensity by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy Alone

4. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: A controlled prospective study

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic Perspective for Optimal Gout Management;Future Pharmacology;2022-05-09

2. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019;Clinical Pharmacokinetics;2020-08-18

3. Detection of Weak Organic Anion–Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans;Drug Metabolism and Disposition;2020-07-28

4. Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing;Transplantation Direct;2020-05-28

5. Probenecid and food effects on flucloxacillin pharmacokinetics and pharmacodynamics in healthy volunteers;Journal of Infection;2020-01